Authors: Matthys, P Vermeire, K Billiau, A

Citation: P. Matthys et al., Mac-1(+) myelopoiesis induced by CFA: a clue to the paradoxical effects ofIFN-gamma in autoimmune disease models, TRENDS IMMU, 22(7), 2001, pp. 367-371

Authors: Matthys, P Hatse, S Vermeire, K Wuyts, A Bridger, G Henson, GW De Clercq, E Billiau, A Schols, D

Citation: P. Matthys et al., AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice, J IMMUNOL, 167(8), 2001, pp. 4686-4692

Authors: Matthys, P Vermeire, K Heremans, H Billiau, A

Citation: P. Matthys et al., The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis, J LEUK BIOL, 68(4), 2000, pp. 447-454

Authors: Vermeire, K Thielemans, L Matthys, P Billiau, A

Citation: K. Vermeire et al., The effects of NO synthase inhibitors on murine collagen-induced arthritisdo not support a role of NO in the protective effect of IFN-gamma, J LEUK BIOL, 68(1), 2000, pp. 119-124

Authors: Matthys, P Vermeire, K Mitera, T Heremans, H Huang, S Schols, D De Wolf-Peeters, C Billiau, A

Citation: P. Matthys et al., Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1(+) myeloid cells, J IMMUNOL, 163(6), 1999, pp. 3503-3510

Authors: Krifa, H Vermeire, K

Citation: H. Krifa et K. Vermeire, Integrating Central European countries in multinational firms' production networks, and the consequences, REV ET COMP, 29(4), 1998, pp. 77-119